Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment for Patients With Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor

NCT00945009 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00945009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00945009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment for Patients With Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
August 24, 2009
Completion date
March 31, 2026
Enrollment
249 (actual)
Sites
169

Conditions

As the registry lists them; a condition with its own page is linked.

adult kidney wilms tumor, beckwith-wiedemann syndrome, childhood kidney wilms tumor, diffuse hyperplastic perilobar nephroblastomatosis, rhabdoid tumor of the kidney, stage i kidney wilms tumor, stage ii kidney wilms tumor, stage iii kidney wilms tumor, stage iv kidney wilms tumor, stage v kidney wilms tumor